Table 2. The association between body composition and testosterone (ng/dL).
Model 1 | Model 2 | Model 3 | |
---|---|---|---|
β (95% CI) P value | β (95% CI) P value | β (95% CI) P value | |
Total | |||
TPF (%) | -18.84 (-19.41, -18.27) <0.001 | -9.25 (-9.90, -8.61) <0.001 | -9.39 (-10.01, -8.77) <0.001 |
APF (%) | -12.84 (-13.40, -12.27) <0.001 | -7.33 (-7.81, -6.85) <0.001 | -7.44 (-7.90, -6.98) <0.001 |
GPF (%) | -18.91 (-19.46, -18.36) <0.001 | -8.36 (-9.06, -7.66) <0.001 | -8.42 (-9.10, -7.73) <0.001 |
A/G | 76.68 (46.61, 106.75) <0.001 | -270.4 (-294.44, -246.37) <0.001 | -283.28 (-306.52, -260.03) <0.001 |
LMP (%) | 20.11 (19.51, 20.70) <0.001 | 9.78 (9.09, 10.47) <0.001 | 9.94 (9.26, 10.61) <0.001 |
Sex | |||
Males | |||
TPF (%) | -12.44 (-13.21, -11.66) <0.001 | -11.97 (-12.80, -11.15) <0.001 | -12.09 (-12.89, -11.29) <0.001 |
APF (%) | -9.52 (-10.07, -8.96) <0.001 | -9.36 (-9.97, -8.75) <0.001 | -9.46 (-10.05, -8.87) <0.001 |
GPF (%) | -10.72 (-11.58, -9.85) <0.001 | -10.29 (-11.18, -9.40) <0.001 | -10.35 (-11.22, -9.48) <0.001 |
A/G | -337.36 (-364.02, -310.71)<0.01 | -320.93 (-351.37, -290.5) <0.01 | -337.24 (-366.67, -307.82) <0.001 |
LMP (%) | 13.17 (12.33, 14.00) <0.001 | 12.62 (11.73, 13.51) <0.001 | 12.76 (11.90, 13.63) <0.001 |
Females | |||
TPF (%) | 0.08 (-0.05, 0.21) 0.24 | 0.19 (0.06, 0.33) <0.01 | 0.20 (0.07, 0.33) <0.01 |
APF (%) | 0.08 (-0.01, 0.18) 0.09 | 0.15 (0.05, 0.25) 0.0043 | 0.17 (0.07, 0.26) <0.01 |
GPF (%) | 0.08 (-0.08, 0.24) 0.31 | 0.15 (-0.01, 0.31) 0.06 | 0.15 (-0.00, 0.30) 0.06 |
A/G | 4.65 (-0.94, 10.24) 0.10 | 7.83 (2.00, 13.67) <0.01 | 8.93 (3.37, 14.49) <0.01 |
LMP (%) | -0.09 (-0.23, 0.05) 0.22 | -0.21 (-0.35, -0.06) <0.01 | -0.22 (-0.36, -0.08) <0.01 |
Notes: No covariate was adjusted in Model 1. Model 2 indicates that analysis was adjusted for age, sex, and race. Model 3 indicates model 2 adjustment plus the adjustment for hypertension, diabetes, hypercholesteremia, smoking status, vigorous work activity.
Sex was not adjusted in the sex-stratified subgroup analyses.